Ascendis Pharma A/S (ASND)
275.39
+8.32
(+3.12%)
USD |
NASDAQ |
Nov 13, 16:00
275.04
-0.35
(-0.13%)
After-Hours: 19:59
Ascendis Pharma Price : 275.39 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 267.40 | 278.56 | 265.62 | 275.39 | 826098.0 |
| Nov 12, 2026 | 264.73 | 269.85 | 258.50 | 267.07 | 1.281M |
| Nov 11, 2026 | 256.84 | 261.53 | 255.85 | 259.28 | 883424.0 |
| Nov 10, 2026 | 258.88 | 259.86 | 255.42 | 256.59 | 829562.0 |
| Nov 09, 2026 | 257.34 | 260.66 | 252.82 | 259.85 | 895979.0 |
| Nov 06, 2026 | 253.45 | 258.46 | 251.02 | 256.82 | 883846.0 |
| Nov 05, 2026 | 257.93 | 257.93 | 251.96 | 253.45 | 557635.0 |
| Nov 04, 2026 | 252.50 | 258.16 | 248.31 | 257.93 | 655805.0 |
| Nov 03, 2026 | 248.57 | 253.01 | 248.57 | 250.17 | 618645.0 |
| Nov 02, 2026 | 252.55 | 254.62 | 248.68 | 248.98 | 479908.0 |
| Oct 30, 2026 | 253.50 | 255.61 | 249.55 | 251.27 | 386705.0 |
| Oct 29, 2026 | 250.62 | 254.20 | 249.56 | 253.00 | 491410.0 |
| Oct 28, 2026 | 246.05 | 249.88 | 243.45 | 249.55 | 660254.0 |
| Oct 27, 2026 | 243.26 | 246.58 | 242.51 | 245.85 | 599081.0 |
| Oct 26, 2026 | 243.56 | 246.40 | 243.35 | 245.15 | 545416.0 |
| Oct 23, 2026 | 242.00 | 244.58 | 240.79 | 243.37 | 575676.0 |
| Oct 22, 2026 | 239.38 | 243.87 | 236.87 | 242.99 | 539178.0 |
| Oct 21, 2026 | 236.00 | 240.21 | 235.50 | 238.90 | 662120.0 |
| Oct 20, 2026 | 230.19 | 235.88 | 229.88 | 234.33 | 394744.0 |
| Oct 19, 2026 | 227.44 | 233.19 | 225.81 | 229.95 | 1.268M |
| Oct 16, 2026 | 226.62 | 226.76 | 223.78 | 225.25 | 680329.0 |
| Oct 15, 2026 | 230.40 | 234.01 | 226.06 | 226.62 | 403968.0 |
| Oct 14, 2026 | 222.54 | 227.83 | 222.00 | 227.00 | 995684.0 |
| Oct 13, 2026 | 225.99 | 228.91 | 222.21 | 223.21 | 592246.0 |
| Oct 12, 2026 | 229.00 | 229.23 | 226.66 | 227.00 | 667448.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| BioMarin Pharmaceutical, Inc. | 57.23 |
| Novo Nordisk A/S | 41.63 |
| Genmab A/S | 51.37 |
| Zealand Pharma A/S | 35.50 |
| Evaxion AS | 2.74 |
Price Related Metrics
| PE Ratio | 17.73 |
| PS Ratio | 12.96 |
| Price to Book Value | 10.60 |
| Price to Free Cash Flow | 30.27 |
| Earnings Yield | 5.64% |
| Market Cap | 18.09B |
| Operating PE Ratio | 70.59 |
| Normalized PE Ratio | 17.73 |